These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34285854)

  • 61. Impact of Insurance Coverage on Outcomes in Primary Breast Sarcoma.
    Koenig JL; Tsai CJ; Sborov K; Horst KC; Pollom EL
    Sarcoma; 2018; 2018():4626174. PubMed ID: 29736143
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Medicaid payer status is linked to increased rates of complications after treatment of proximal humerus fractures.
    Sabesan VJ; Petersen-Fitts G; Lombardo D; Briggs D; Whaley J
    J Shoulder Elbow Surg; 2017 Jun; 26(6):948-953. PubMed ID: 28094189
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis.
    Kang M; Choi J; Kim J; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Park SH; Song C; Seo SI
    J Cancer; 2020; 11(24):7202-7208. PubMed ID: 33193883
    [No Abstract]   [Full Text] [Related]  

  • 64. Effect of insurance type on perioperative outcomes after robotic-assisted pulmonary lobectomy for lung cancer.
    Deol PS; Sipko J; Kumar A; Tsalatsanis A; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
    Surgery; 2019 Aug; 166(2):211-217. PubMed ID: 31202473
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer.
    Pezzi TA; Schwartz DL; Pisters KMW; Mohamed ASR; Welsh JW; Chang JY; Liao Z; Gandhi SJ; Byers LA; Minsky BD; Fuller CD; Chun SG
    JAMA Netw Open; 2020 Apr; 3(4):e203277. PubMed ID: 32320035
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Management trends for anaplastic meningioma with adjuvant radiotherapy and predictors of long-term survival.
    Alhourani A; Aljuboori Z; Yusuf M; Woo SY; Hattab EM; Andaluz N; Williams BJ
    Neurosurg Focus; 2019 Jun; 46(6):E4. PubMed ID: 31153143
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Managing acute cholecystitis among Medicaid insured in New York State: opportunities to optimize care.
    Stey AM; Greenstein AJ; Aufses A; Moskowitz AJ; Egorova NN
    Surg Endosc; 2018 May; 32(5):2212-2221. PubMed ID: 29435753
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy.
    Fu WF; Chen QX; Wang XX; Zhang J; Song CG
    Front Oncol; 2020; 10():1753. PubMed ID: 33102205
    [No Abstract]   [Full Text] [Related]  

  • 70. A Multi-institutional Analysis of Insurance Status as a Predictor of Morbidity Following Breast Reconstruction.
    Vieira BL; Lanier ST; Mlodinow AS; Bethke KP; Murphy RX; Hume KM; Gutowski KA; Fine NA; Kim JY
    Plast Reconstr Surg Glob Open; 2014 Nov; 2(11):e255. PubMed ID: 25506538
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Five Steps to Successfully Implement and Evaluate Propensity Score Matching in Clinical Research Studies.
    Staffa SJ; Zurakowski D
    Anesth Analg; 2018 Oct; 127(4):1066-1073. PubMed ID: 29324498
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012.
    Brower JV; Chen S; Bassetti MF; Yu M; Harari PM; Ritter MA; Baschnagel AM
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):985-993. PubMed ID: 27869098
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Efficacy of Long-Term Chinese Herbal Medicine Use on Lung Cancer Survival Time: A Retrospective Two-Center Cohort Study with Propensity Score Matching.
    Xu LL; Zhang SF; Wang YL; Luo YB; Fang ZH; Fang Y; Xu RZ; Guo P; Wu JC; Li Y
    Evid Based Complement Alternat Med; 2021; 2021():5522934. PubMed ID: 34475962
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment outcomes of locally advanced cervical cancer by histopathological types in a single institution: A propensity score matching study.
    Yin KC; Lu CH; Lin JC; Hsu CY; Wang L
    J Formos Med Assoc; 2018 Oct; 117(10):922-931. PubMed ID: 30025761
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Effect of Type 2 Diabetes Mellitus on the Short-Term Outcomes and Prognosis of Stage I-III Colorectal Cancer: A Propensity Score Matching Analysis.
    Cheng Y; Cheng YX; Liu XY; Kang B; Tao W; Peng D
    Cancer Manag Res; 2022; 14():205-214. PubMed ID: 35046727
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association between length of stay and postoperative survival in patients with lung cancer: a propensity score matching analysis based on National Cancer Database.
    Kong W; Wang H; Chen Y; Xie J; Huang B; Fang L; Chen W; Shao W; Zhang J
    J Thorac Dis; 2023 Apr; 15(4):1785-1793. PubMed ID: 37197503
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Effect of Complications on Oncological Outcomes of Colorectal Cancer Patients After Primary Surgery: A Propensity Score Matching Analysis.
    Liu XY; Zhang B; Kang B; Cheng YX; Yuan C; Tao W; Wei ZQ; Peng D
    Front Oncol; 2022; 12():857062. PubMed ID: 35719908
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of immunotherapy use in patients with stage IV pancreatic carcinoma.
    Guddati AK; Komiya T; Patel SJ; Sharma N; Powell E
    J Gastrointest Oncol; 2020 Aug; 11(4):654-662. PubMed ID: 32953149
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Marital status impacts survival of stage I non-small-cell lung cancer: a propensity-score matching analysis.
    Qiu LH; Song JQ; Jiang F; Zhao YY; Liu Y; Wu LL; Ma GW
    Future Sci OA; 2024; 10(1):FSO926. PubMed ID: 38827800
    [No Abstract]   [Full Text] [Related]  

  • 80. Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis.
    Li Q; Chang Z; Wang T; Liu B; Wang X; Ge XY; Yang T; Liu Q; Wang W
    Front Oncol; 2022; 12():989080. PubMed ID: 36505810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.